Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,442,724 papers from all fields of science
Search
Sign In
Create Free Account
cancer therapy
Known as:
Malignant Neoplasm Treatment
, Cancer Treatment
, cancer therapies
Expand
Any intervention for management of a malignant neoplasm.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Molecular Pathways Molecular Pathways : CDK 4 Inhibitors for Cancer Therapy
M. Dickson
2014
Corpus ID: 15243659
Unrestrained growth is the hallmark of cancer, and disrupted cell-cycle regulation is, therefore, common. CDK4 is the key…
Expand
Review
2010
Review
2010
Eph Receptors and Ephrin Ligands: Important Players in Angiogenesis and Tumor Angiogenesis
B. Mosch
,
Bettina Reissenweber
,
Christin Neuber
,
Jens Pietzsch
Journal of Oncology
2010
Corpus ID: 6103068
Eph receptors and their ephrin ligands were identified in the late 1980's. Subsequently, they were linked to different…
Expand
Highly Cited
2006
Highly Cited
2006
Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): a new type of mastectomy for breast cancer treatment
J. Petit
,
U. Veronesi
,
+11 authors
C. Casadio
Breast Cancer Research and Treatment
2006
Corpus ID: 21359357
SummaryBackgroundBreast-conserving surgery has become the standard approach for about 80% of patients treated for primary breast…
Expand
Highly Cited
2006
Highly Cited
2006
Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer
Zhihong Ai
,
L. Yin
,
+4 authors
Youji Feng
Cancer
2006
Corpus ID: 13629214
Endometrial cancer is a common gynecologic malignancy among women. The molecular mechanisms involved in the progression of…
Expand
Highly Cited
2005
Highly Cited
2005
In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy
S. Xi
,
W. Gooding
,
J. Grandis
Oncogene
2005
Corpus ID: 25119742
The development of more effective prevention and treatment strategies for solid tumors is limited by an incomplete understanding…
Expand
Highly Cited
2005
Highly Cited
2005
Enhancement of Drug Delivery in Tumors by Using Interaction of Nanoparticles with Ultrasound Radiation
I. Larina
,
B. Evers
,
T. Ashitkov
,
C. Bartels
,
K. Larin
,
R. Esenaliev
Technology in Cancer Research and Treatment
2005
Corpus ID: 26088698
Efficacy and safety of cancer chemo- and biotherapy are limited by poor penetration of anti-cancer drugs from blood into tumor…
Expand
Review
2004
Review
2004
New anticancer strategies targeting HIF-1.
E. Yeo
,
Y. Chun
,
Jong-Wan Park
Biochemical Pharmacology
2004
Corpus ID: 24452915
Highly Cited
2002
Highly Cited
2002
Autocrine Production of Interleukin 1β Confers Constitutive Nuclear Factor κB Activity and Chemoresistance in Pancreatic Carcinoma Cell Lines
A. Arlt
,
Jens Vorndamm
,
+4 authors
H. Schäfer
2002
Corpus ID: 1517968
We have recently shown that several pancreatic carcinoma cell lines are resistant to topoisomerase IIα inhibitors due to elevated…
Expand
Highly Cited
1997
Highly Cited
1997
Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and…
C. Isaacs
,
N J Robert
,
+7 authors
J. A. Kaye
Journal of Clinical Oncology
1997
Corpus ID: 23244829
PURPOSE Thrombocytopenia may compromise cancer treatment, causing chemotherapy dose reductions, schedule alterations, or the need…
Expand
Review
1995
Review
1995
Life and death by P53
R. Elledge
,
Wen-Hwa Lee
Bioessays
1995
Corpus ID: 8727855
p53 is a multifunctional protein which plays a role in modulating gene transcription, policing cell cycle checkpoints, activating…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE